NCT05947539

Brief Summary

This study will develop and pilot test a couples-based intervention to help adolescent girls and young women living with HIV (WLHIV (15-24 years) living in Uganda access HIV care and improve the outcomes of their HIV treatment by targeting male partner alcohol use to reduce IPV risk.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Jul 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Jul 2023Oct 2026

First Submitted

Initial submission to the registry

March 22, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

December 26, 2025

Status Verified

August 1, 2025

Enrollment Period

3.3 years

First QC Date

March 22, 2023

Last Update Submit

December 23, 2025

Conditions

Outcome Measures

Primary Outcomes (6)

  • change from baseline in antiretroviral therapy (ART) adherence biomarker (females and HIV+ male partners)

    presence of Tenofoivir Disoproxil Fumarate (TDF) detected in urine

    3 and 6 month follow up

  • change from baseline in self-reported antiretroviral therapy (ART) adherence (females and HIV+ male partners)

    Self- report of missed ART using the AIDS Clinical Trials Group Adherence (AACTG) measures

    3 and 6 month follow up

  • change from baseline in HIV care engagement (females and HIV+ male partners)

    HIV clinic visit adherence

    3 months, 6 months

  • change from baseline in phosphatidylethanol (PEth) (male partners)

    alcohol biomarker (PEth) levels

    6 months

  • change from baseline in heavy drinking (male partners)

    assessed with the Alcohol Use Disorders Identification Test (AUDIT-C)

    3 months, 6 months

  • Intimate partner violence (IPV) occurence (males and females)

    Any incident of IPV perpetration and victimization: physical, sexual, verbal/emotional, intimidation and/or controlling behavior measured using the World Health Organization (WHO) Instrument/ Demographic and Health Data (DHS) Domestic Violence Modules.

    6 months

Secondary Outcomes (1)

  • Fear of intimate partner violence (males and females)

    6 month follow up

Other Outcomes (3)

  • change from baseline in HIV viral load (females and HIV+ males)

    6 months

  • change from baseline in PrEP adherence (male partners taking PrEP)

    3 and 6 month follow up

  • PrEP uptake

    through 6 month follow-up

Study Arms (2)

Kisoboka Mukwano Intervention (treatment)

EXPERIMENTAL

A brief couples-based intervention using motivational interviewing, peer navigation, and behavioral economic approaches to target intimate partner violence, alcohol use, and HIV care engagement.

Behavioral: Kisoboka Mukwano ("It is possible, my love!") Intervention

Screening & Referral (control)

ACTIVE COMPARATOR

Brief feedback on intimate partner violence and alcohol use (males), referrals for these conditions, and briefly discuss the importance of HIV care engagement and adherence.

Behavioral: Screening and Referral

Interventions

The intervention consists of 5 bi-weekly sessions each lasting 60 to 90 minutes. It uses motivational interviewing, peer navigation, and behavioral economics to promote strategies for economic strengthening, reductions in male partner alcohol use, coping with relationship conflict and stress, changing norms that reduce intimate partner violence and support engagement in HIV care and antiretroviral therapy (ART) adherence among adolescent girls and young women living with HIV, and, thereby, enhances future sustained viral suppression and benefits of treatment as prevention.

Kisoboka Mukwano Intervention (treatment)

Intimate partner violence screening, alcohol screening, and referral

Screening & Referral (control)

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adolescent girls and young women (AGYW)/Female:
  • aged 18-24 or self-reported as emancipated minors aged 15-17,
  • HIV+
  • meets one or more of the following non-engagement criteria: not currently enrolled in an HIV clinic (e.g., never enrolled, dropped out); not currently taking ART; missed 1 or more scheduled HIV care appointments requiring physical presence (e.g., viral load \[VL\] testing) in the last 12 months; \< 90% ART adherence in the last 2 weeks; most recent VL\>1000 or expected recent VL test results absent in clinic records despite initiating ART \>6 months ago
  • self-report a history of at least one incident of IPV (physical, sexual, and/or emotional) and/or controlling behavior ever perpetrated by their current male partner
  • agree to let research staff contact their male partner.
  • Male Partners of AGYW/Male:
  • aged 18+ years or emancipated minors
  • report consuming ≥ 6 drinks per occasion at least once or more in the prior 30 days or scores 4 or more on the AUDIT (Alcohol Use Disorders Identification Test)-C
  • Couples (each partner (male and female) must independently report):
  • married or living together as if married for ≥6 months
  • planning to stay together for at least another 2 months (intervention period)
  • lived in the Wakiso District area ≥3 months
  • not planning to move from the area within the next 6 months
  • respond similarly (not exact but close) to questions on the study-developed Couple Verification Screening

You may not qualify if:

  • AGYW (female):
  • reporting any severe physical IPV experienced in prior 3 months.
  • Couples (male and female):
  • do not speak Luganda or English
  • do not feel they cannot safely participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Makerere Univerisity School of Public Health

Kampala, Uganda

Location

Related Publications (1)

  • Nwabuzor Ogbonnaya I, Nakigudde J, Naigino R, Stockman JK, Chung Y, Nantongo M, Marsiglia FF, Hahn JA, Wechsberg WM, Mwebembezi A, Wanyenze RK, Kiene SM. Protocol for the Kisoboka Mukwano pilot randomized controlled trial in Uganda: A couples-based intervention to reduce intimate partner violence and alcohol use among adolescent girls and young women living with HIV and their male partners. Contemp Clin Trials. 2025 Dec;159:108136. doi: 10.1016/j.cct.2025.108136. Epub 2025 Nov 7.

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeAlcoholism

Interventions

MethodsMass ScreeningReferral and Consultation

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Investigative TechniquesDiagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health PracticeProfessional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Ijeoma Nwabuzor Ogbonnaya, PhD

    Arizona State University

    PRINCIPAL INVESTIGATOR
  • Susan M Kiene, PhD

    San Diego State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 22, 2023

First Posted

July 17, 2023

Study Start

July 1, 2023

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

December 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All collected individual participant data (IPD) that underlie the 6-month clinical trial, excluding qualitative data and data collected for formative research.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Two years after the grant end date specified on the first Notice of Award (08-31-2025). Any subject-level data and the associated analyzed data used in a journal publication will be shared at the time of publication, even if the publication occurs before the two-year automatic share date.
Access Criteria
Access to data for research purposes will be provided through the National Institute of Mental Health (NIMH) Data Archive (NDA) Data Access Committee (DAC). Investigators and institutions seeking data from NDA will be expected to meet data security measures and will be asked to submit a Data Use Certification, which is cosigned by the investigator and the designated Institutional Official(s) at the NIH-recognized sponsoring institution with a current Federal Wide Assurance (FWA).
More information

Locations